Clinical Implications of p57KIP2 Expression in Breast Cancer |
Xu, Xiao-Yin
(Department of Surgical Oncology and Department of Breast Surgery, the First Hospital of China Medical University)
Wang, Wen-Qian (Department of Surgical Oncology and Department of Breast Surgery, the First Hospital of China Medical University) Zhang, Lei (Department of Surgical Oncology and Department of Breast Surgery, the First Hospital of China Medical University) Li, Yi-Ming (Department of Surgical Oncology and Department of Breast Surgery, the First Hospital of China Medical University) Tang, Miao (Department of Surgical Oncology and Department of Breast Surgery, the First Hospital of China Medical University) Jiang, Nan (Department of Surgical Oncology and Department of Breast Surgery, the First Hospital of China Medical University) Cai, Shou-Liang (Department of Surgical Oncology and Department of Breast Surgery, the First Hospital of China Medical University) Wei, Liang (Department of Surgical Oncology and Department of Breast Surgery, the First Hospital of China Medical University) Jin, Feng (Department of Surgical Oncology and Department of Breast Surgery, the First Hospital of China Medical University) Chen, Bo (Department of Surgical Oncology and Department of Breast Surgery, the First Hospital of China Medical University) |
1 | Kondo M, Matsuoka S, Uchida K, et al (1996). Selective maternal-allele loss in human lung cancers of the maternally expressed P57-KIP2 gene at 11p15.5. Oncogene, 12, 1365-8. |
2 | Lichy JH, Zavar M, Tsai MM, et al (1998). Loss of heterozygosity on chromosome 11p15 during histological progression in microdissected ductal carcinoma of the breast. Am J Pathol, 153, 271-8. DOI |
3 | Li Y, Millikan RC, Newman B, et al (1999). P57(KIP2) polymorphisms and breast cancer risk. Hum Genet, 104, 83-8. DOI |
4 | Matsuoka S, Edwards MC, Bai C, et al (1995). , a structurally distinct member of the p21CIP Cdk inhibitor family is a candidate tumor suppressor gene. Gene Dev, 9, 650-62. DOI ScienceOn |
5 | Matsuoka S, Thompson J, Edwards M, et al (1996). Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor,P57-KIP2, on chromosome 11p15. P Natl Acad Sci USA, 93, 3026-30. DOI |
6 | Procter M, Suter TM, de Azambuja E, et al (2010). Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trial. J Clin Oncol, 28, 3422-8. DOI |
7 | Seizinger B, Deimling A (1991). Report of the committee on chromosome and gene loss in human neoplasia. Cytogenet Cell Genet, 58, 1080-96. DOI |
8 | Tokino T, Urano T, Furuhata T, et al (1996). Characterization of the human gene:alternative splicing, insertion/deletion polymorphisms in VNTR sequences in the coding region, and mutational analysis. Hum Genet, 97, 625-31. DOI |
9 | Zhang P, Liegeois N, Wong C, et al (1997). Altered cell differentiation and proliferation in mice lacking P57-KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature, 387, 151-63. DOI |
10 | Buiting K, Kanber D, Horsthemke B, et al (2010). Imprinting of RB1( the new kid on the block). Brief Funct Genomics, 9, 347-53. DOI |
11 | De P, Smith BR, Leyland-Jones B (2010). Human epidermal growth factor receptor 2 testing: where are we? J Clin Oncol, 28, 4289-92 DOI |
12 | Duman-Scheel M, Weng L, Xin SJ, et al (2002). Hedgehog regulates cell growth and proliferation by inducing cyclin D and cyclin E. Nature, 417, 299-304. DOI ScienceOn |
13 | Eddy AA (1996). Expression of genes that promote renal interstitial fibrosis in rats with proteinuria. Kidney Int, 54, S49-54. |
14 | Gudmundsson J, Barkardottir RB, Eiriksdottir G, et al (1995). Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations. Brit J Cancer, 72, 696-701. DOI |
15 | Guran S, Bahce M, Beyan C, Korkmaz K, Yalcin A (1998). P53, p15INK4B, p16INK4A and p57KIP2 mutations during the progression of chronic myeloid leukemia. Haematologia (Budap), 29, 181-93. |
16 | Hatada I, Inazawa J, Nakayama M, et al (1996). Genomic imprinting of human P57-KIP2 and its reduced expression in Wilms' tumors. Hum Mol Genet, 5, 783-8. DOI |
17 | Karnik P, Paris M, Williams BRG, T, et al (1998). wo distinct tumor suppressor loci within chromosome 11p15 implicated in breast cancer progression and metastatsis. Hum Mol Genet, 7, 895-903. DOI |
18 | Kavanagh E, Joseph B (2011). The hallmarks of CDKN1C (p57, KIP2) in cancer. Biochim Biophys Acta, 1816, 50-6. |
19 | Koepp DM, Schaefer LK, Ye X, et al (2001). Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw 7 ubiquitin ligase. Science, 294, 173-7. DOI |